Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks

Background C1 esterase inhibitor (C1-INH) replacement is recommended as a first-line therapy for acute edema attacks in hereditary angioedema (HAE). Only limited pharmacokinetic analyses of the administered C1-INH in plasma are available. Objective To investigate retrospectively the population pharm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of allergy, asthma, & immunology asthma, & immunology, 2010-08, Vol.105 (2), p.149-154
Hauptverfasser: Bernstein, Jonathan A., MD, Ritchie, Bruce, MD, Levy, Robyn J., MD, Wasserman, Richard L., MD, PhD, Bewtra, Againdra K., MD, Hurewitz, David S., MD, Obtulowicz, Krystyna, MD, Reshef, Avner, MD, Moldovan, Dumitru, MD, Shirov, Todor, MD, Grivcheva-Panovska, Vesna, MD, Kiessling, Peter C., PhD, Schindel, Fritz, MS, Craig, Timothy J., DO
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!